CK-1827452

DRUG3 trials

Sponsors

Cytokinetics

Conditions

Heart Failure

Phase 2

A Study of CK-1827452 Infusion in Stable Heart Failure

CompletedNCT00624442

CytokineticsHeart Failure

Start: 2007-04-30End: 2009-02-28Updated: 2021-05-14

Phase II Study of the Effect of CK-1827452 Injection on Myocardial Efficiency

TerminatedNCT00748579

CytokineticsHeart Failure

Start: 2008-09-30End: 2009-07-31Updated: 2020-01-21

Pharmacokinetics of Oral CK-1827452 in Patients With Stable Heart Failure

CompletedNCT00941681

CytokineticsHeart Failure

Start: 2009-04-30End: 2009-10-31Updated: 2013-02-12

Related Papers

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.

2011-08-01251 citations